A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
|Effective start/end date||7/30/15 → 12/31/27|
- BRIGHAM AND WOMEN'S HOSPITAL
- NIH NATIONAL CANCER INSTITUTE (NCI)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.